Akèy › Dyabèt Tip 2 › Georgia › Atlanta
Etid klinik pou Dyabèt Tip 2 nan Atlanta, GA
17 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Ap rekriteVolontè an sante akeyi
- Randomize Now, LLC - Noir Research Collective, Riverdale · 12 mi lwen
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Stockbridge · 17 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Decatur · 6 mi lwen
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- Emory University School of Medicine, Atlanta
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Ap rekriteFaz 2
- SKY Clinical Research Network Group-Brown, Atlanta
- Pivotal Research Solutions, Stonecrest · 15 mi lwen
Peanuts for Cardiometabolic, Brain, and Intestinal Health
Ap rekrite
- Georgia State University, Atlanta
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
Ap rekrite
- Georgia State University, Atlanta
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Atlanta
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Decatur · 6 mi lwen
- Research Site, Conyers · 22 mi lwen
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Ap rekriteEtid obsèvasyon
- Research Site, Decatur · 6 mi lwen
Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
Ap rekrite
- Emory Healthcare, Atlanta
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Ap rekriteFaz 3
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Ap rekriteFaz 3
- Research Site, Decatur · 6 mi lwen
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Ap rekrite
- Emory University, Atlanta
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
Ap rekriteFaz 3
- Grady Memorial Hospital, Atlanta
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Ap rekrite
- EMORY, Atlanta
- Atlanta Diabetes Associates, Atlanta
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Ap rekriteFaz 4
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL24 etid
- Boston, MA20 etid
- Miami, FL19 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
- New York City, NY16 etid
Lòt etid nan Atlanta
- Kansè (tout kalite)49 etid
- Kansè Poumon ki pa ti selil47 etid
- Kansè nan tete41 etid
- Myelom Miltip41 etid
- Kansè pwostat33 etid
- Leksemi mieloïd egi30 etid
- Kansè ovè29 etid
- Kansè poumon29 etid
- Kansè kolorektal29 etid
- Kansè Metastatik28 etid
- Ensifizyans kadyak25 etid
- Twoub depresif majè25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.